299 related articles for article (PubMed ID: 6975652)
1. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.
Lotze MT; Grimm EA; Mazumder A; Strausser JL; Rosenberg SA
Cancer Res; 1981 Nov; 41(11 Pt 1):4420-5. PubMed ID: 6975652
[TBL] [Abstract][Full Text] [Related]
2. Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.
Mazumder A; Grimm EA; Zhang HZ; Rosenberg SA
Cancer Res; 1982 Mar; 42(3):913-8. PubMed ID: 7059990
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.
Belldegrun A; Muul LM; Rosenberg SA
Cancer Res; 1988 Jan; 48(1):206-14. PubMed ID: 3257161
[TBL] [Abstract][Full Text] [Related]
4. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
[TBL] [Abstract][Full Text] [Related]
5. Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer.
Rosenberg SA; Eberlein TJ; Grimm EA; Lotze MT; Mazumder A; Rosenstein M
Surgery; 1982 Aug; 92(2):328-36. PubMed ID: 6980492
[TBL] [Abstract][Full Text] [Related]
6. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
7. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
8. Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70.
Wei Y; Zhao X; Kariya Y; Fukata H; Teshigawara K; Uchida A
Cancer Res; 1996 Mar; 56(5):1104-10. PubMed ID: 8640768
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes.
Rabinowich H; Cohen R; Bruderman I; Steiner Z; Klajman A
Cancer Res; 1987 Jan; 47(1):173-7. PubMed ID: 3491673
[TBL] [Abstract][Full Text] [Related]
10. Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens.
Strausser JL; Mazumder A; Grimm EA; Lotze MT; Rosenberg SA
J Immunol; 1981 Jul; 127(1):266-71. PubMed ID: 7195411
[TBL] [Abstract][Full Text] [Related]
11. Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression.
Pawelec G; Rehbein A; Müller C; Sonneborn HH; Wernet P
Immunology; 1981 Apr; 42(4):529-40. PubMed ID: 6453828
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies of the long-term growth of lymphocytes from tumor infiltrates, tumor-draining lymph nodes, and peripheral blood by repeated in vitro stimulation with autologous tumor.
Skornick Y; Topalian S; Rosenberg SA
J Biol Response Mod; 1990 Aug; 9(4):431-8. PubMed ID: 2395007
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of cytotoxic lymphocytes against autologous cholangiocarcinoma from the patient's blood lymphocytes cultured in T cell growth factor (TCGF)].
Yoshizumi Y
Nihon Geka Gakkai Zasshi; 1984 Jun; 85(6):563-72. PubMed ID: 6092889
[TBL] [Abstract][Full Text] [Related]
14. Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
Chang AE; Yoshizawa H; Sakai K; Cameron MJ; Sondak VK; Shu S
Cancer Res; 1993 Mar; 53(5):1043-50. PubMed ID: 8439951
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
Mizutani Y; Okada Y; Terachi T; Yoshida O
J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
[TBL] [Abstract][Full Text] [Related]
16. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
[TBL] [Abstract][Full Text] [Related]
17. Expansion of autorecognitive cytotoxic effectors in human cancer by T cell growth factor (Interleukin 2)1.
Vose BM
Arch Geschwulstforsch; 1981; 51(4):317-26. PubMed ID: 6459065
[TBL] [Abstract][Full Text] [Related]
18. Cytolysis of autologous fresh osteosarcoma cells by human cytotoxic T lymphocytes propagated with T cell growth factor.
Ichino Y; Ishikawa T
Gan; 1983 Aug; 74(4):584-94. PubMed ID: 6605270
[TBL] [Abstract][Full Text] [Related]
19. Growth of human normal and leukemic T cells: T-cell growth factor (TCGF) and the isolation of a new class of RNA tumor viruses (HTLV).
Gallo RC
Blood Cells; 1981; 7(2):313-29. PubMed ID: 6975142
[TBL] [Abstract][Full Text] [Related]
20. In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.
Yron I; Wood TA; Spiess PJ; Rosenberg SA
J Immunol; 1980 Jul; 125(1):238-45. PubMed ID: 6966652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]